US Patent Issued to FOSHAN ZHONGKE RHYTHM BIOTECH on July 7 for "Myogenin-expressing fibroblast-like cell (MEFLC) line and construction method and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,674,140, issued on July 7, was assigned to FOSHAN ZHONGKE RHYTHM BIOTECH Co. LTD. (Foshan, China).

"Myogenin-expressing fibroblast-like cell (MEFLC) line and construction method and use thereof" was invented by Bin Lin (Foshan, China), Weiwei Kong (Foshan, China), Lishi Zhou (Foshan, China), Ping Wang (Foshan, China), Zebin Lin (Foshan, China), Qiang Gao (Foshan, China), Jianzheng Cen (Foshan, China) and Jian Zhuang (Foshan, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "A myogenin-expressing fibroblast-like cell (MEFLC) line and a construction method and a use thereof are provided. The MEFLC line was deposited in the Guangdong Microbial Culture Co...